CureVac Still Hopes Variants Could Win Favor For COVID-19 Vaccine
Trial Shows Overall Protection Rate Of 48%
Patients 18-60 had a protection rate of 53%, but there were too few cases among those older than 60 – a crucial subgroup – in HERALD to draw conclusions about the vaccine’s efficacy among older people.
